Merck (MRK) Equity Income (2009 - 2014)

Merck (MRK) has reported Equity Income for 5 consecutive years, with $16.0 million the latest figure, recorded in Q4 2014.

• On a quarterly basis, Equity Income fell 69.81% year-over-year to $16.0 million in Q4 2014; TTM through Dec 2014 was $256.0 million, a 36.63% decrease from a year earlier, with the FY2014 full-year figure at $257.0 million, down 36.39% from the prior year.
• Equity Income was $16.0 million for Q4 2014 at Merck, down from $24.0 million in the prior quarter.
• Over five years, Equity Income peaked at $256.0 million in Q4 2011 and troughed at $16.0 million in Q4 2014.
• A 4-year average of $122.8 million and a median of $120.0 million in 2013 frame the typical range for Equity Income.
• The widest YoY moves for Equity Income: up 20.91% in 2013, down 77.16% in 2013.
• Over 4 years, Equity Income stood at $256.0 million in 2011, then retreated by 9.38% to $232.0 million in 2012, then tumbled by 77.16% to $53.0 million in 2013, then tumbled by 69.81% to $16.0 million in 2014.
• The last three Equity Income figures came in at $16.0 million (Q4 2014), $24.0 million (Q3 2014), and $92.0 million (Q2 2014), per Business Quant data.